Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent
These findings highlight potential emodepside toxicity risks with extralabel use of the FDA-approved topical feline product and help inform safe off-label use in dogs.
Authors
- Jeba R. J. Jesudoss Chelladurai (ORCID: https://orcid.org/0000-0003-3077-0201)
- Maria C. Jugan (ORCID: https://orcid.org/0000-0002-6963-7646)
- Stephanie E. Martinez (ORCID: https://orcid.org/0000-0001-8430-4973)
- Theresa A. Quintana (ORCID: https://orcid.org/0000-0003-1266-3349)
- Erin J. Mayhue
- Greta N. Karwath
Institutions
- Utah State University (US)
- Kansas State University (US)
- Auburn University (US)
Publication Details
- Journal
- American Journal of Veterinary Research
- Published
- 2025-04-04
- DOI
- https://doi.org/10.2460/ajvr.25.01.0027
- Citations
- 4
- Primary Topic
- Helminth infection and control
- Type
- article
- Field-Weighted Citation Impact
- 9.42
Funders
- National Institutes of Health
- College of Veterinary Medicine, Kansas State University
- NIH Office of the Director